T cell activation antigens: therapeutic implications.
Williams
J M
JM
Department of Medicine, Beth Israel Hospital and Harvard Medical School, Boston, MA 02215.
Kelley
V E
VE
Kirkman
R L
RL
Tilney
N L
NL
Shapiro
M E
ME
Murphy
J R
JR
Strom
T B
TB
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000938:Antigen-Presenting Cells; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology*; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D011971:Receptors, Immunologic / Q000502:physiology; D015375:Receptors, Interleukin-2; D013601:T-Lymphocytes / Q000276:immunology*; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7